Bristol-Myers Squibb Research and Development, Princeton, NJ 08543-4000, USA
Abstract:
A useful and novel set of tool molecules have been identified which bind irreversibly to the JAK3 active site cysteine residue. The design was based on crystal structure information and a comparative study of several electrophilic warheads.